Ignite Creation Date:
2025-12-24 @ 11:18 PM
Ignite Modification Date:
2026-01-03 @ 9:58 PM
Study NCT ID:
NCT02605356
Status:
WITHDRAWN
Last Update Posted:
2016-10-07
First Post:
2015-11-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase 1b/2 Study Testing Radium-223 Dichloride/Bortezomib/Dexamethasone Combination in Relapsed Multiple Myeloma
Sponsor:
Bayer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-10
Start Date Type:
None
Primary Completion Date:
2019-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-07
Completion Date Type:
ESTIMATED
First Submit Date:
2015-11-12
First Submit QC Date:
None
Study First Post Date:
2015-11-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-10-06
Last Update Post Date:
2016-10-07
Last Update Post Date Type:
ESTIMATED